All PlansAdministrativeMedium impact
Voluntary nationwide recall: Methocarbamol (Eugia - March)
UPMC Health Plan·Pharmacy, Pain Management, Orthopedics +1 more·Pharmacy
Effective date
Mar 28, 2024
We identified it
Aug 7, 2026
Summary
Eugia US LLC is recalling one lot of Methocarbamol Injection 1000 mg/10 mL due to white particles found in vials that could cause local irritation, swelling, or life-threatening blood clots. The billing team must identify patients who received this recalled medication and coordinate with clinical staff to ensure affected patients are notified and the medication is returned.
Action Required
Immediately: Clinical and billing teams must identify all patients who received Methocarbamol Injection from the recalled lot. Coordinate with providers to contact affected patients and instruct them to stop use and return medication to pharmacy. Document all patient contacts and medication returns in patient records and billing system. Verify with pharmacy that no claims are submitted for the recalled lot. If claims have already been submitted for affected patients, flag them for review and potential adjustment. No new claims should be processed for this recalled medication until lot status is verified. Contact Eugia US LLC at 866-850-2876 option 2 or visit FDA website to confirm lot number and patient eligibility.